Nuformix PLC NFX:London Stock Exchange

RT Quote | Exchange | GBp
Last | 4:35 PM BST
2.30quote price arrow up+0.20 (+9.52%)
52 week range
1.83 - 6.40

...

Loading . . .
  • Open2.10
  • Day High2.30
  • Day Low2.30
  • Prev Close2.10
  • 52 Week High6.40
  • 52 Week High Date08/19/20
  • 52 Week Low1.83
  • 52 Week Low Date03/10/21

Key Stats

  • Market Cap14.91M
  • Shares Out513.36M
  • 10 Day Average Volume5.95M
  • Dividend-
  • Dividend Yield-
  • Beta-0.04
  • YTD % Change-14.81

KEY STATS

  • Open2.10
  • Day High2.30
  • Day Low2.30
  • Prev Close2.10
  • 52 Week High6.40
  • 52 Week High Date08/19/20
  • 52 Week Low1.83
  • 52 Week Low Date03/10/21
  • Market Cap14.91M
  • Shares Out513.36M
  • 10 Day Average Volume5.95M
  • Dividend-
  • Dividend Yield-
  • Beta-0.04
  • YTD % Change-14.81

RATIOS/PROFITABILITY

  • EPS (TTM)-0.23
  • P/E (TTM)-10.00
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nuformix PLC

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Nuformix PLC, formerly Levrett PLC, is a United Kingdom-based pharmaceutical development company. The Company uses cocrystal technology to develop drugs with programs in oncology supportive care and fibrosis. It uses cocrystal technology to re-engineer the crystalline form of drugs. Its clinical pipeline includes NXP001 and NXP002. Its pre-clinical pipeline includes NXP003. It is developing NXP001 for oncology supportive care. It is developing NXP002 for the treatment of...
Address
153 Science Park, Milton Road
Cambridge
CB4 0GN
United Kingdom